Adiponectin inhibits the binding of low-density lipoprotein to biglycan, a vascular proteoglycan

被引:13
作者
Kobayashi, K [1 ]
Inoguchi, T [1 ]
Sonoda, N [1 ]
Sekiguchi, N [1 ]
Nawata, H [1 ]
机构
[1] Kyushu Univ, Grad Sch Med Sci, Dept Med & Bioregulat Sci, Fukuoka 812, Japan
关键词
adiponectin; biglycan; extracellular matrices; proteoglycan; LDL retention; apolipoprotein B; full-length; globular; atherosclerosis; solid-phase plate assays;
D O I
10.1016/j.bbrc.2005.07.048
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The aim of this study was to test the possibility that adiponectin has an antiatherogenic effect through the inhibition of LDL binding to proteoglycans, an initial event in atherogenesis. Both full-length and globular adiponectin inhibited LDL binding in a dose-dependent manner. Both types of adiponectin bound to biglycan in a dose-dependent manner. Immunoprecipitation and immunoblotting analysis showed interaction of full-length adiponectin with LDL. Pretreatment of biglycan with globular adiponectin prior to LDL addition diminished the inhibitory effect, while pretreatment with full-length adiponectin retained the effect. This is a new antiatherogenic property that appears independent of the receptor-mediated hormonal action of adiponectin. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:66 / 70
页数:5
相关论文
共 29 条
[1]   Decreased plasma adiponectin concentration in patients with essential hypertension [J].
Adamczak, M ;
Wiecek, A ;
Funahashi, T ;
Chudek, J ;
Kokot, F ;
Matsuzawa, Y .
AMERICAN JOURNAL OF HYPERTENSION, 2003, 16 (01) :72-75
[2]   Adipocyte-derived plasma protein adiponectin acts as a platelet-derived growth factor-BB-binding protein and regulates growth factor-induced common postreceptor signal in vascular smooth muscle cell [J].
Arita, Y ;
Kihara, S ;
Ouchi, N ;
Maeda, K ;
Kuriyama, H ;
Okamoto, Y ;
Kumada, M ;
Hotta, K ;
Nishida, M ;
Takahashi, M ;
Nakamura, T ;
Shimomura, I ;
Muraguchi, M ;
Ohmoto, Y ;
Funahashi, T ;
Matsuzawa, Y .
CIRCULATION, 2002, 105 (24) :2893-2898
[3]   Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity [J].
Arita, Y ;
Kihara, S ;
Ouchi, N ;
Takahashi, M ;
Maeda, K ;
Miyagawa, J ;
Hotta, K ;
Shimomura, I ;
Nakamura, T ;
Miyaoka, K ;
Kuriyama, H ;
Nishida, M ;
Yamashita, S ;
Okubo, K ;
Matsubara, K ;
Muraguchi, M ;
Ohmoto, Y ;
Funahashi, T ;
Matsuzawa, Y .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 257 (01) :79-83
[4]  
Bdeir K, 1999, BLOOD, V94, P2007
[5]   Identification of the low density lipoprotein receptor-binding site in apolipoprotein B100 and the modulation of its binding activity by the carboxyl terminus in familial defective apo-B100 [J].
Borén, J ;
Lee, I ;
Zhu, WM ;
Arnold, K ;
Taylor, S ;
Innerarity, TL .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (05) :1084-1093
[6]  
CAMEJO G, 1991, J LIPID RES, V32, P1983
[7]   Identification of the proteoglycan binding site in apolipoprotein B48 [J].
Flood, C ;
Gustafsson, M ;
Richardson, PE ;
Harvey, SC ;
Segrest, JP ;
Borén, J .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (35) :32228-32233
[8]   DISTRIBUTION AND CHEMICAL COMPOSITION OF ULTRACENTRIFUGALLY SEPARATED LIPOPROTEINS IN HUMAN SERUM [J].
HAVEL, RJ ;
EDER, HA ;
BRAGDON, JH .
JOURNAL OF CLINICAL INVESTIGATION, 1955, 34 (09) :1345-1353
[9]   Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients [J].
Hotta, K ;
Funahashi, T ;
Arita, Y ;
Takahashi, M ;
Matsuda, M ;
Okamoto, Y ;
Iwahashi, H ;
Kuriyama, H ;
Ouchi, N ;
Maeda, K ;
Nishida, M ;
Kihara, S ;
Sakai, N ;
Nakajima, T ;
Hasegawa, K ;
Muraguchi, M ;
Ohmoto, Y ;
Nakamura, T ;
Yamashita, S ;
Hanafusa, T ;
Matsuzawa, Y .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2000, 20 (06) :1595-1599
[10]   EFFECT OF ARTERIAL PROTEOGLYCANS AND GLYCOSAMINOGLYCANS ON LOW-DENSITY-LIPOPROTEIN OXIDATION AND ITS UPTAKE BY HUMAN MACROPHAGES AND ARTERIAL SMOOTH-MUSCLE CELLS [J].
HURTCAMEJO, E ;
CAMEJO, G ;
ROSENGREN, B ;
LOPEZ, F ;
AHLSTROM, C ;
FAGER, G ;
BONDJERS, G .
ARTERIOSCLEROSIS AND THROMBOSIS, 1992, 12 (05) :569-583